KARACHI: A rights issue is one of the main ways a listed company raises fresh capital from its own shareholders. Instead of selling new shares to the public, the company offers them first to the people who already own its shares, usually at a price below the market price. Zarea Limited's Rs3 billion rights issue, announced to the PSX on 19 November, is a clear example of how the process works.
The ratio: how many new shares you are offered
Every rights issue states a ratio. Zarea's is 16 new shares for every 35 shares held, so a shareholder holding 350 shares is entitled to subscribe for 160 new shares. In Zarea's case, 120 million new shares at Rs25 each add up to Rs3 billion, about 45.71 per cent of the company's existing paid-up capital. The entitlement is proportional, so a shareholder who takes up the full entitlement keeps the same percentage ownership as before, while one who does not take part sees their holding diluted.
The price: why rights are usually offered at a discount
The offer price is normally set below the market price to encourage shareholders to subscribe. Zarea's offer price is Rs25 per share, made up of a face value of Re1 plus a premium of Rs24. That is 29.30 per cent below the closing price of Rs35.36 on 23 October 2026, and 40.82 per cent below the six-month average closing price of Rs42.24, according to Mettis Global. The discount does not mean the shares are cheap in any absolute sense: the market price usually adjusts after the issue, because the same company value is spread across more shares.
Book closure: who qualifies
Only shareholders on the register at a set date qualify. Zarea's book closure is 24 November 2026, for one day, and share transfers lodged by the close of business on 23 November 2026 count for entitlement. Anyone who buys shares after that cut-off does not receive the rights. The record date, the ratio and the offer price are set out in the offer document, dated 16 November 2026 and valid until 15 February 2027.
Trading the rights: use them, sell them or let them lapse
A shareholder who receives rights has three choices: subscribe and pay for the new shares, sell the rights themselves on the exchange, or do nothing and let the rights lapse. The rights are traded separately as "unpaid rights" for a limited window, in Zarea's case from 26 November to 10 December 2026. A shareholder who does not want to put in more money can sell the rights to another investor, who then pays for the shares. The subscription payment deadline is 17 December 2026, although one table in the offer document lists a payment date of 10 December 2026, so shareholders should check the company's announcements. Allotment and credit of the new shares to CDS accounts is scheduled for 1 January 2027.
What the company does with the money
The offer document must state how the proceeds will be used. Zarea plans to use Rs2 billion, about two-thirds of the Rs3 billion, to repay the principal of a privately placed short-term Sukuk issued on 6 October 2026 and repayable on 5 April 2027. Net proceeds are Rs2,951.5 million, of which Rs951.5 million will be used as additional working capital. The directors and sponsors have committed Rs1.5 billion, half the issue, and the balance is underwritten by Dawood Equities, Adam Securities, Pak Libya Holding and K-Trade. The full announcement is covered in our report on Zarea's rights issue. This article is educational content, not financial advice.
Key takeaway: A rights issue offers existing shareholders new shares in proportion to what they hold, usually at a discount; Zarea's 16-for-35 offer at Rs25 shows the ratio, the book closure, the trading of unpaid rights and the payment deadline in practice.